✦ LIBER ✦

Comparison of suppressor and cytotoxic activity of blood mononuclears during adaptive immunotherapy of cancer patients with lymphokine-activated killer cells with a low dose of recombinant interleukin-2

✍ Scribed by I. F. Abronina; T. A. Kupriyanova; A. V. Bolvachova; S. N. Bykovskaya; O. M. Dronova; L. I. Buachidze

Publisher: Springer US
Year: 1991
Tongue: English
Weight: 345 KB
Volume: 112
Category: Article
ISSN: 0007-4888
DOI: 10.1007/bf00840432

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The augmentation of lymphokine-activated

The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2

✍ C. R. D. Carter; B. W. Hancock; R. C. Rees 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 925 KB

A regimen of surgical adjuvant immunothe

A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells

✍ Tokujiro Yano; Teruyoshi Ishida; Ichiro Yoshino; Mitsuhiro Murata; Kosei Yasumot 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 670 KB

Recombinant interleukin-2 and lymphokine

Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cells

✍ Claudio Fortis; Elisabetta Ferrero; Carlo Besana; Mauro Biffi; Silvia Heltai; La 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 735 KB

Cytotoxic cell function and phenotypic a

Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C

✍ Shinya Arinaga; Nobuya Karimine; Masashi Adachi; Hiroshi Inoue; Shigeru Nanbara; 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 758 KB

Persistent augmentation of natural-kille

Persistent augmentation of natural-killer-and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose

✍ P. A. Palmer; J. G. M. Scharenberg; B. M. E. von Blomberg; A. G. M. Stam; C. J. 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 744 KB

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t